Significant MP calls for BCM Strains (IMPC_001)  

 

Total number of results: 539

Gene / Allele Procedure Parameter Zygosity Sex Phenotype P-value Graph
Aph1a
Aph1atm1b(KOMP)Mbp
Gross Morphology Embryo E9.5 Embryo Size homozygote Male abnormal embryo size 0.0
Aph1a
Aph1atm1b(KOMP)Mbp
Gross Morphology Embryo E9.5 Embryo Size homozygote Female abnormal embryo size 0.0
Aph1a
Aph1atm1b(KOMP)Mbp
Gross Morphology Embryo E18.5 Embryo Size homozygote Male abnormal embryo size 0.0
Ddx39
Ddx39tm1b(KOMP)Wtsi
Gross Morphology Embryo E12.5 Embryo Size homozygote Male abnormal embryo size 0.0
Ddx39
Ddx39tm1b(KOMP)Wtsi
Gross Morphology Embryo E18.5 Embryo Size homozygote Male abnormal embryo size 0.0
Ddx39
Ddx39tm1b(KOMP)Wtsi
Gross Morphology Embryo E18.5 Embryo Size homozygote Female abnormal embryo size 0.0
Itgb8
Itgb8tm1b(KOMP)Wtsi
Gross Morphology Embryo E18.5 Embryo Size homozygote Female abnormal embryo size 0.0
Zfp609
Zfp609tm1b(EUCOMM)Hmgu
Gross Morphology Embryo E18.5 Embryo Size homozygote Male abnormal embryo size 0.0
Aph1a
Aph1atm1b(KOMP)Mbp
Gross Morphology Embryo E9.5 Embryo Size heterozygote Female abnormal embryo size 0.0
Aph1a
Aph1atm1b(KOMP)Mbp
Gross Morphology Embryo E18.5 Embryo Size heterozygote Female abnormal embryo size 0.0
Ddx39
Ddx39tm1b(KOMP)Wtsi
Gross Morphology Embryo E18.5 Embryo Size heterozygote Female abnormal embryo size 0.0
Itgb8
Itgb8tm1b(KOMP)Wtsi
Gross Morphology Embryo E18.5 Embryo Size heterozygote Female abnormal embryo size 0.0
Zfp609
Zfp609tm1b(EUCOMM)Hmgu
Gross Morphology Embryo E18.5 Embryo Size heterozygote Female abnormal embryo size 0.0
Aph1a
Aph1atm1b(KOMP)Mbp
Gross Morphology Embryo E9.5 Pale yolk sac homozygote Male pale yolk sac 0.0
Aph1a
Aph1atm1b(KOMP)Mbp
Gross Morphology Embryo E9.5 Pale yolk sac homozygote Female pale yolk sac 0.0
Aph1a
Aph1atm1b(KOMP)Mbp
Gross Morphology Embryo E18.5 Responsive to tactile stimuli homozygote Male unresponsive to tactile stimuli 0.0
Ddx39
Ddx39tm1b(KOMP)Wtsi
Gross Morphology Embryo E18.5 Responsive to tactile stimuli homozygote Female unresponsive to tactile stimuli 0.0
Ddx39
Ddx39tm1b(KOMP)Wtsi
Gross Morphology Embryo E18.5 Responsive to tactile stimuli homozygote Male unresponsive to tactile stimuli 0.0
G3bp1
G3bp1tm1b(KOMP)Wtsi
Gross Morphology Embryo E18.5 Responsive to tactile stimuli homozygote Female unresponsive to tactile stimuli 0.0
G3bp1
G3bp1tm1b(KOMP)Wtsi
Gross Morphology Embryo E18.5 Responsive to tactile stimuli homozygote Male unresponsive to tactile stimuli 0.0
Itgb8
Itgb8tm1b(KOMP)Wtsi
Gross Morphology Embryo E18.5 Responsive to tactile stimuli homozygote Female unresponsive to tactile stimuli 0.0
Lrrfip1
Lrrfip1tm1.1(KOMP)Wtsi
Gross Morphology Embryo E18.5 Responsive to tactile stimuli homozygote Female unresponsive to tactile stimuli 0.0
Lrrfip1
Lrrfip1tm1.1(KOMP)Wtsi
Gross Morphology Embryo E18.5 Responsive to tactile stimuli homozygote Male unresponsive to tactile stimuli 0.0
Zfp609
Zfp609tm1b(EUCOMM)Hmgu
Gross Morphology Embryo E18.5 Responsive to tactile stimuli homozygote Female unresponsive to tactile stimuli 0.0
Zfp609
Zfp609tm1b(EUCOMM)Hmgu
Gross Morphology Embryo E18.5 Responsive to tactile stimuli homozygote Male unresponsive to tactile stimuli 0.0
Aph1a
Aph1atm1b(KOMP)Mbp
Gross Morphology Embryo E18.5 Responsive to tactile stimuli heterozygote Female unresponsive to tactile stimuli 0.0
Aph1a
Aph1atm1b(KOMP)Mbp
Gross Morphology Embryo E18.5 Responsive to tactile stimuli heterozygote Male unresponsive to tactile stimuli 0.0
Ddx39
Ddx39tm1b(KOMP)Wtsi
Gross Morphology Embryo E18.5 Responsive to tactile stimuli heterozygote Female unresponsive to tactile stimuli 0.0
Ddx39
Ddx39tm1b(KOMP)Wtsi
Gross Morphology Embryo E18.5 Responsive to tactile stimuli heterozygote Male unresponsive to tactile stimuli 0.0
G3bp1
G3bp1tm1b(KOMP)Wtsi
Gross Morphology Embryo E18.5 Responsive to tactile stimuli heterozygote Male unresponsive to tactile stimuli 0.0
G3bp1
G3bp1tm1b(KOMP)Wtsi
Gross Morphology Embryo E18.5 Responsive to tactile stimuli heterozygote Female unresponsive to tactile stimuli 0.0
Itgb8
Itgb8tm1b(KOMP)Wtsi
Gross Morphology Embryo E18.5 Responsive to tactile stimuli heterozygote Female unresponsive to tactile stimuli 0.0
Itgb8
Itgb8tm1b(KOMP)Wtsi
Gross Morphology Embryo E18.5 Responsive to tactile stimuli heterozygote Male unresponsive to tactile stimuli 0.0
Lrrfip1
Lrrfip1tm1.1(KOMP)Wtsi
Gross Morphology Embryo E18.5 Responsive to tactile stimuli heterozygote Male unresponsive to tactile stimuli 0.0
Lrrfip1
Lrrfip1tm1.1(KOMP)Wtsi
Gross Morphology Embryo E18.5 Responsive to tactile stimuli heterozygote Female unresponsive to tactile stimuli 0.0
Zfp609
Zfp609tm1b(EUCOMM)Hmgu
Gross Morphology Embryo E18.5 Responsive to tactile stimuli heterozygote Male unresponsive to tactile stimuli 0.0
Zfp609
Zfp609tm1b(EUCOMM)Hmgu
Gross Morphology Embryo E18.5 Responsive to tactile stimuli heterozygote Female unresponsive to tactile stimuli 0.0
Aph1a
Aph1atm1b(KOMP)Mbp
Gross Morphology Embryo E9.5 Pallor homozygote Male pallor 0.0
Aph1a
Aph1atm1b(KOMP)Mbp
Gross Morphology Embryo E9.5 Pallor homozygote Female pallor 0.0
Gpr173
Gpr173em2Bay
Combined SHIRPA and Dysmorphology Skin color - tail homozygote Female abnormal skin coloration 0.0
Gpr173
Gpr173em2Bay
Combined SHIRPA and Dysmorphology Skin color - tail homozygote Male abnormal skin coloration 0.0
Itgb8
Itgb8tm1b(KOMP)Wtsi
Gross Morphology Embryo E9.5 Hemorrhage homozygote Female hemorrhage 0.0
Ddx39
Ddx39tm1b(KOMP)Wtsi
Gross Morphology Placenta E12.5 Placenta Vasculature homozygote Male abnormal placenta vasculature 0.0
Prdm14
Prdm14tm1a(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Bone Mineral Density (excluding skull) homozygote Female decreased bone mineral density 1.7733220905628694E-25
Prdm14
Prdm14tm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Bone Mineral Density (excluding skull) homozygote Female decreased bone mineral density 1.5114276060414816E-21
Dnase1l2
Dnase1l2tm1.1(KOMP)Wtsi
Grip Strength Forelimb grip strength measurement mean homozygote Female decreased grip strength 9.983872891884709E-21
Dnase1l2
Dnase1l2tm1.1(KOMP)Wtsi
Grip Strength Forelimb grip strength measurement mean homozygote Male decreased grip strength 9.983872891884709E-21
Dnase1l2
Dnase1l2tm1.1(KOMP)Wtsi
Grip Strength Forelimb grip strength measurement mean heterozygote Female decreased grip strength 9.983872891884709E-21
Dnase1l2
Dnase1l2tm1.1(KOMP)Wtsi
Grip Strength Forelimb grip strength measurement mean heterozygote Male decreased grip strength 9.983872891884709E-21
Kcng2
Kcng2em2Bay
Electrocardiogram (ECG) PQ homozygote Female shortened PQ interval 2.7421580143409855E-20
Kcng2
Kcng2em2Bay
Electrocardiogram (ECG) PQ homozygote Male shortened PQ interval 2.7421580143409855E-20
Patl1
Patl1tm1b(EUCOMM)Wtsi
Grip Strength Forelimb and hindlimb grip strength measurement mean heterozygote Male decreased grip strength 7.597929222347174E-20
Iqsec3
Iqsec3tm3b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Lean mass homozygote Male decreased lean body mass 1.0832273401336107E-18
Iqsec3
Iqsec3tm3b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Fat/Body weight homozygote Male increased total body fat amount 4.472624301897712E-18
Iqsec3
Iqsec3tm3b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Fat mass homozygote Male increased total body fat amount 1.116435167569042E-17
Prdm14
Prdm14tm1a(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) BMC/Body weight homozygote Female decreased bone mineral content 1.3058521659362336E-17
Dnase1l2
Dnase1l2tm1.1(KOMP)Wtsi
Grip Strength Forelimb and hindlimb grip strength measurement mean homozygote Female decreased grip strength 4.0068522992950254E-17
Dnase1l2
Dnase1l2tm1.1(KOMP)Wtsi
Grip Strength Forelimb and hindlimb grip strength measurement mean homozygote Male decreased grip strength 4.0068522992950254E-17
Dnase1l2
Dnase1l2tm1.1(KOMP)Wtsi
Grip Strength Forelimb and hindlimb grip strength measurement mean heterozygote Female decreased grip strength 4.0068522992950254E-17
Dnase1l2
Dnase1l2tm1.1(KOMP)Wtsi
Grip Strength Forelimb and hindlimb grip strength measurement mean heterozygote Male decreased grip strength 4.0068522992950254E-17
Iqsec3
Iqsec3tm3b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Lean/Body weight homozygote Male decreased lean body mass 1.249372935455603E-16
Pdx1
Pdx1tm1b(EUCOMM)Wtsi
Intraperitoneal glucose tolerance test (IPGTT) Area under glucose response curve heterozygote Female impaired glucose tolerance 2.6001150682694563E-16
Pdx1
Pdx1tm1b(EUCOMM)Wtsi
Intraperitoneal glucose tolerance test (IPGTT) Area under glucose response curve heterozygote Male impaired glucose tolerance 2.6001150682694563E-16
Prdm14
Prdm14tm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) BMC/Body weight homozygote Female decreased bone mineral content 4.242360545856223E-16
Greb1
Greb1tm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Body length homozygote Female decreased body length 8.761977739359236E-16
Greb1
Greb1tm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Body length homozygote Male decreased body length 8.761977739359236E-16
Prdm14
Prdm14em2Bay
Body Composition (DEXA lean/fat) Bone Mineral Density (excluding skull) homozygote Female decreased bone mineral density 1.0047861632959541E-15
Rnf10
Rnf10tm1b(KOMP)Wtsi
Acoustic Startle and Pre-pulse Inhibition (PPI) Response amplitude - S homozygote Female decreased startle reflex 9.598241255612261E-14
Rnf10
Rnf10tm1b(KOMP)Wtsi
Acoustic Startle and Pre-pulse Inhibition (PPI) Response amplitude - S homozygote Male decreased startle reflex 9.598241255612261E-14
Prdm14
Prdm14tm1a(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Bone Mineral Content (excluding skull) homozygote Female decreased bone mineral content 6.262158760289571E-13
Kcng2
Kcng2em2Bay
Electrocardiogram (ECG) PR homozygote Female shortened PR interval 9.621679538177053E-13
Kcng2
Kcng2em2Bay
Electrocardiogram (ECG) PR homozygote Male shortened PR interval 9.621679538177053E-13
Rnf10
Rnf10tm1b(KOMP)Wtsi
Combined SHIRPA and Dysmorphology Unexpected behaviors homozygote Female abnormal behavior 2.7555570672466168E-11
Iqsec3
Iqsec3tm3b(KOMP)Wtsi
Body Composition (DEXA lean/fat) BMC/Body weight homozygote Female decreased bone mineral content 2.965835216306445E-11
Iqsec3
Iqsec3tm3b(KOMP)Wtsi
Body Composition (DEXA lean/fat) BMC/Body weight homozygote Male decreased bone mineral content 2.965835216306445E-11
Iqsec3
Iqsec3tm3b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Bone Mineral Content (excluding skull) homozygote Female decreased bone mineral content 4.0495350128733065E-11
Iqsec3
Iqsec3tm3b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Bone Mineral Content (excluding skull) homozygote Male decreased bone mineral content 4.0495350128733065E-11
Scarb1
Scarb1tm1b(EUCOMM)Wtsi
Electrocardiogram (ECG) rMSSD heterozygote Female cardiovascular system phenotype 2.404082488638437E-10
Slc44a1
Slc44a1tm1b(EUCOMM)Hmgu
Combined SHIRPA and Dysmorphology Coat - hair texture / appearance - back homozygote Male abnormal coat appearance 7.765827980676931E-10
Tead1
Tead1tm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Fat/Body weight heterozygote Female increased total body fat amount 1.358560930420083E-9
Tead1
Tead1tm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Fat/Body weight heterozygote Male decreased total body fat amount 1.358560930420083E-9
Iqsec3
Iqsec3tm3b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Bone Area homozygote Female abnormal bone structure 2.08757300335094E-9
Iqsec3
Iqsec3tm3b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Bone Area homozygote Male abnormal bone structure 2.08757300335094E-9
Iqsec3
Iqsec3tm3b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Bone Mineral Density (excluding skull) homozygote Female decreased bone mineral density 3.2920053349982936E-9
Iqsec3
Iqsec3tm3b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Bone Mineral Density (excluding skull) homozygote Male decreased bone mineral density 3.2920053349982936E-9
Slc44a1
Slc44a1tm1b(EUCOMM)Hmgu
Body Composition (DEXA lean/fat) Fat/Body weight homozygote Female decreased total body fat amount 4.360455108098904E-9
Slc44a1
Slc44a1tm1b(EUCOMM)Hmgu
Body Composition (DEXA lean/fat) Fat/Body weight homozygote Male decreased total body fat amount 4.360455108098904E-9
Aldob
Aldobtm2b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Bone Mineral Density (excluding skull) homozygote Female decreased bone mineral density 7.655221345714835E-9
Aldob
Aldobtm2b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Bone Mineral Density (excluding skull) homozygote Male decreased bone mineral density 7.655221345714835E-9
Prdm14
Prdm14tm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Bone Mineral Content (excluding skull) homozygote Female decreased bone mineral content 7.805600610311103E-9
Prdm14
Prdm14tm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Bone Mineral Content (excluding skull) homozygote Male decreased bone mineral content 7.805600610311103E-9
Tead1
Tead1tm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Fat mass heterozygote Female increased total body fat amount 1.2292702855631887E-8
Tead1
Tead1tm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Fat mass heterozygote Male decreased total body fat amount 1.2292702855631887E-8
Prdm14
Prdm14tm1a(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Lean/Body weight homozygote Female decreased lean body mass 1.2874973975840476E-8
Prdm14
Prdm14em2Bay
Body Composition (DEXA lean/fat) BMC/Body weight homozygote Female decreased bone mineral content 1.5481630200042673E-8
Ap4e1
Ap4e1tm1b(KOMP)Wtsi
Echo Stroke Volume homozygote Female decreased cardiac stroke volume 1.8234045384701858E-8
Ap4e1
Ap4e1tm1b(KOMP)Wtsi
Echo Stroke Volume homozygote Male decreased cardiac stroke volume 1.8234045384701858E-8
Spidr
Spidrtm1b(EUCOMM)Hmgu
Body Composition (DEXA lean/fat) BMC/Body weight homozygote Female decreased bone mineral content 1.9251912064532917E-8
Prdm14
Prdm14tm1a(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Fat mass homozygote Female increased total body fat amount 2.7837323557378113E-8
Prdm14
Prdm14tm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Fat/Body weight homozygote Female increased total body fat amount 4.842288348072543E-8
Ap4e1
Ap4e1tm1b(KOMP)Wtsi
Echo Cardiac Output homozygote Female decreased cardiac output 5.5122058029155596E-8
Ap4e1
Ap4e1tm1b(KOMP)Wtsi
Echo Cardiac Output homozygote Male decreased cardiac output 5.5122058029155596E-8
Pptc7
Pptc7tm1b(EUCOMM)Hmgu
Combined SHIRPA and Dysmorphology Coat - hair texture / appearance - back homozygote Male abnormal coat appearance 5.765681976299675E-8
Pptc7
Pptc7tm1b(EUCOMM)Hmgu
Combined SHIRPA and Dysmorphology Coat - hair texture / appearance - back heterozygote Male abnormal coat appearance 5.765681976299675E-8
Il12rb1
Il12rb1tm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Fat/Body weight homozygote Male decreased total body fat amount 5.839205030611083E-8
Erg
Ergem1Bay
Echo LVPWs heterozygote Female thick ventricular wall 6.00295777530846E-8
Erg
Ergem1Bay
Echo LVPWs heterozygote Male thick ventricular wall 6.00295777530846E-8
Prdm14
Prdm14em2Bay
Body Composition (DEXA lean/fat) Bone Mineral Content (excluding skull) homozygote Female decreased bone mineral content 6.491797677199429E-8
Nr1d1
Nr1d1tm1(KOMP)Vlcg
Body Composition (DEXA lean/fat) BMC/Body weight homozygote Female increased bone mineral content 6.615764647222022E-8
Nr1d1
Nr1d1tm1(KOMP)Vlcg
Body Composition (DEXA lean/fat) BMC/Body weight homozygote Male increased bone mineral content 6.615764647222022E-8
Nr1d1
Nr1d1tm1(KOMP)Vlcg
Body Composition (DEXA lean/fat) BMC/Body weight heterozygote Female increased bone mineral content 6.615764647222022E-8
Nr1d1
Nr1d1tm1(KOMP)Vlcg
Body Composition (DEXA lean/fat) BMC/Body weight heterozygote Male increased bone mineral content 6.615764647222022E-8
Slc44a1
Slc44a1tm1b(EUCOMM)Hmgu
Combined SHIRPA and Dysmorphology Coat - hair texture / appearance - head homozygote Male abnormal coat appearance 8.632859049839681E-8
Spidr
Spidrtm1b(EUCOMM)Hmgu
Body Composition (DEXA lean/fat) Bone Mineral Density (excluding skull) homozygote Female decreased bone mineral density 9.074788209773033E-8
Spidr
Spidrtm1b(EUCOMM)Hmgu
Body Composition (DEXA lean/fat) Bone Mineral Density (excluding skull) homozygote Male decreased bone mineral density 9.074788209773033E-8
Tfeb
Tfebtm1a(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Lean/Body weight heterozygote Female decreased lean body mass 9.404821099678884E-8
Tfeb
Tfebtm1a(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Lean/Body weight heterozygote Male increased lean body mass 9.404821099678884E-8
Alg10b
Alg10btm1(KOMP)Vlcg
Indirect Calorimetry Respiratory Exchange Ratio heterozygote Male decreased respiratory quotient 9.932605138374129E-8
Ctdspl2
Ctdspl2tm2b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Fat mass heterozygote Male decreased total body fat amount 1.0225357982562855E-7
Ctdspl2
Ctdspl2tm2b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Fat mass homozygote Male decreased total body fat amount 1.0225357982562855E-7
Cyp7b1
Cyp7b1tm1b(EUCOMM)Wtsi
Intraperitoneal glucose tolerance test (IPGTT) Initial response to glucose challenge homozygote Female impaired glucose tolerance 1.0858151711090613E-7
Iqsec3
Iqsec3tm3b(KOMP)Wtsi
Acoustic Startle and Pre-pulse Inhibition (PPI) Response amplitude - S homozygote Female decreased startle reflex 1.0983846721046575E-7
Iqsec3
Iqsec3tm3b(KOMP)Wtsi
Acoustic Startle and Pre-pulse Inhibition (PPI) Response amplitude - S homozygote Male decreased startle reflex 1.0983846721046575E-7
Il12rb1
Il12rb1tm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Fat mass homozygote Male decreased total body fat amount 1.2093201462448633E-7
Ap4e1
Ap4e1tm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Fat/Body weight homozygote Male decreased total body fat amount 1.289808153615013E-7
Nr1d1
Nr1d1tm1(KOMP)Vlcg
Body Composition (DEXA lean/fat) Fat/Body weight homozygote Female decreased total body fat amount 1.354930105890162E-7
Nr1d1
Nr1d1tm1(KOMP)Vlcg
Body Composition (DEXA lean/fat) Fat/Body weight homozygote Male decreased total body fat amount 1.354930105890162E-7
Nr1d1
Nr1d1tm1(KOMP)Vlcg
Body Composition (DEXA lean/fat) Fat/Body weight heterozygote Female decreased total body fat amount 1.354930105890162E-7
Nr1d1
Nr1d1tm1(KOMP)Vlcg
Body Composition (DEXA lean/fat) Fat/Body weight heterozygote Male decreased total body fat amount 1.354930105890162E-7
Tfeb
Tfebtm1a(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Lean mass heterozygote Male increased lean body mass 1.3633234630106017E-7
Nr1d1
Nr1d1tm1(KOMP)Vlcg
Body Composition (DEXA lean/fat) Fat mass homozygote Female decreased total body fat amount 1.5125782226732554E-7
Nr1d1
Nr1d1tm1(KOMP)Vlcg
Body Composition (DEXA lean/fat) Fat mass homozygote Male decreased total body fat amount 1.5125782226732554E-7
Nr1d1
Nr1d1tm1(KOMP)Vlcg
Body Composition (DEXA lean/fat) Fat mass heterozygote Female decreased total body fat amount 1.5125782226732554E-7
Nr1d1
Nr1d1tm1(KOMP)Vlcg
Body Composition (DEXA lean/fat) Fat mass heterozygote Male decreased total body fat amount 1.5125782226732554E-7
Hmmr
Hmmrtm1b(EUCOMM)Hmgu
X-ray Tibia length homozygote Male short tibia 1.56921473148941E-7
Scarb1
Scarb1tm1b(EUCOMM)Wtsi
Electrocardiogram (ECG) HR heterozygote Female decreased heart rate 1.627813759341734E-7
Scarb1
Scarb1tm1b(EUCOMM)Wtsi
Electrocardiogram (ECG) HR heterozygote Male decreased heart rate 1.627813759341734E-7
Pla2g4e
Pla2g4etm2b(EUCOMM)Hmgu
Grip Strength Forelimb and hindlimb grip strength measurement mean homozygote Male decreased grip strength 1.635518174225581E-7
Pla2g4e
Pla2g4etm2b(EUCOMM)Hmgu
Grip Strength Forelimb and hindlimb grip strength measurement mean heterozygote Male decreased grip strength 1.635518174225581E-7
Pla2g4e
Pla2g4etm2b(EUCOMM)Hmgu
Grip Strength Forelimb and hindlimb grip strength measurement mean homozygote Female increased grip strength 1.635518174225581E-7
Pla2g4e
Pla2g4etm2b(EUCOMM)Hmgu
Grip Strength Forelimb and hindlimb grip strength measurement mean heterozygote Female increased grip strength 1.635518174225581E-7
Spata5
Spata5tm1b(KOMP)Wtsi
Hematology Mean corpuscular hemoglobin heterozygote Female increased mean corpuscular hemoglobin 1.6544058212275559E-7
Kcng2
Kcng2em2Bay
Electrocardiogram (ECG) HR homozygote Female increased heart rate 1.7189336176670622E-7
Kcng2
Kcng2em2Bay
Electrocardiogram (ECG) HR homozygote Male increased heart rate 1.7189336176670622E-7
Spidr
Spidrtm1b(EUCOMM)Hmgu
Body Composition (DEXA lean/fat) Fat/Body weight homozygote Female increased total body fat amount 1.7232505911124463E-7
Spidr
Spidrtm1b(EUCOMM)Hmgu
Body Composition (DEXA lean/fat) Fat/Body weight homozygote Male increased total body fat amount 1.7232505911124463E-7
Tbccd1
Tbccd1tm1b(EUCOMM)Hmgu
Combined SHIRPA and Dysmorphology Skin color - tail homozygote Male abnormal skin coloration 2.0165549585726694E-7
Bhmt
Bhmttm1b(EUCOMM)Hmgu
Body Composition (DEXA lean/fat) Fat mass homozygote Male decreased total body fat amount 2.2171830948991555E-7
Prdm14
Prdm14tm1a(EUCOMM)Wtsi
Intraperitoneal glucose tolerance test (IPGTT) Area under glucose response curve homozygote Female impaired glucose tolerance 2.3111263658393E-7
Col1a2
Col1a2tm1b(EUCOMM)Wtsi
Echo LVIDd homozygote Female dilated heart left ventricle 2.5047904728126014E-7
Col1a2
Col1a2tm1b(EUCOMM)Wtsi
Echo LVIDd homozygote Male dilated heart left ventricle 2.5047904728126014E-7
Prdm14
Prdm14tm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Bone Area homozygote Female abnormal bone structure 2.6407386144455813E-7
Bhmt
Bhmttm1b(EUCOMM)Hmgu
Body Composition (DEXA lean/fat) Lean mass homozygote Male increased lean body mass 3.031593962532497E-7
Nr1d1
Nr1d1tm1(KOMP)Vlcg
Body Composition (DEXA lean/fat) Bone Area homozygote Female abnormal bone structure 3.2115255521603103E-7
Nr1d1
Nr1d1tm1(KOMP)Vlcg
Body Composition (DEXA lean/fat) Bone Area homozygote Male abnormal bone structure 3.2115255521603103E-7
Nr1d1
Nr1d1tm1(KOMP)Vlcg
Body Composition (DEXA lean/fat) Bone Area heterozygote Female abnormal bone structure 3.2115255521603103E-7
Nr1d1
Nr1d1tm1(KOMP)Vlcg
Body Composition (DEXA lean/fat) Bone Area heterozygote Male abnormal bone structure 3.2115255521603103E-7
Gdpd5
Gdpd5tm1b(EUCOMM)Hmgu
Combined SHIRPA and Dysmorphology Skin color - tail homozygote Male abnormal skin coloration 3.9108471128201927E-7
Lrrfip1
Lrrfip1tm1.1(KOMP)Wtsi
Combined SHIRPA and Dysmorphology Skin color - tail heterozygote Male abnormal skin coloration 3.9108471128201927E-7
Tead1
Tead1tm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Lean mass heterozygote Female decreased lean body mass 4.30106268822783E-7
Tead1
Tead1tm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Lean mass heterozygote Male increased lean body mass 4.30106268822783E-7
Tead1
Tead1tm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Lean/Body weight heterozygote Female decreased lean body mass 4.714312922260433E-7
Tead1
Tead1tm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Lean/Body weight heterozygote Male increased lean body mass 4.714312922260433E-7
Kcng2
Kcng2em2Bay
Echo Stroke Volume homozygote Female decreased cardiac stroke volume 4.907645347884682E-7
Kcng2
Kcng2em2Bay
Echo Stroke Volume homozygote Male decreased cardiac stroke volume 4.907645347884682E-7
Tmem132a
Tmem132atm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Bone Area heterozygote Female abnormal bone structure 5.047896820542519E-7
Tmem132a
Tmem132atm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Bone Area heterozygote Male abnormal bone structure 5.047896820542519E-7
Mogs
Mogstm1(KOMP)Vlcg
Body Composition (DEXA lean/fat) Bone Mineral Density (excluding skull) heterozygote Female decreased bone mineral density 5.175832029635785E-7
Mogs
Mogstm1(KOMP)Vlcg
Body Composition (DEXA lean/fat) Bone Mineral Density (excluding skull) heterozygote Male decreased bone mineral density 5.175832029635785E-7
Smco2
Smco2tm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Lean mass homozygote Female increased lean body mass 5.180360176382237E-7
Smco2
Smco2tm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Lean mass homozygote Male increased lean body mass 5.180360176382237E-7
Alg10b
Alg10btm1.1(KOMP)Vlcg
Intraperitoneal glucose tolerance test (IPGTT) Fasted blood glucose concentration heterozygote Female decreased fasted circulating glucose level 5.747655791310535E-7
Alg10b
Alg10btm1.1(KOMP)Vlcg
Intraperitoneal glucose tolerance test (IPGTT) Fasted blood glucose concentration heterozygote Male increased fasted circulating glucose level 5.747655791310535E-7
Ctdspl2
Ctdspl2tm2b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Fat/Body weight heterozygote Female decreased total body fat amount 6.121486535448639E-7
Ctdspl2
Ctdspl2tm2b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Fat/Body weight heterozygote Male decreased total body fat amount 6.121486535448639E-7
Ctdspl2
Ctdspl2tm2b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Fat/Body weight homozygote Female decreased total body fat amount 6.121486535448639E-7
Ctdspl2
Ctdspl2tm2b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Fat/Body weight homozygote Male decreased total body fat amount 6.121486535448639E-7
Col1a2
Col1a2tm1b(EUCOMM)Wtsi
Echo LVIDs homozygote Female dilated heart left ventricle 6.773497034373577E-7
Col1a2
Col1a2tm1b(EUCOMM)Wtsi
Echo LVIDs homozygote Male dilated heart left ventricle 6.773497034373577E-7
Ism2
Ism2tm3b(EUCOMM)Hmgu
Acoustic Startle and Pre-pulse Inhibition (PPI) % Pre-pulse inhibition - PPI3 homozygote Female increased prepulse inhibition 7.014590437393053E-7
Ism2
Ism2tm3b(EUCOMM)Hmgu
Acoustic Startle and Pre-pulse Inhibition (PPI) % Pre-pulse inhibition - PPI3 homozygote Male increased prepulse inhibition 7.014590437393053E-7
Hibadh
Hibadhtm1b(EUCOMM)Wtsi
Clinical Chemistry Alkaline phosphatase homozygote Female decreased circulating alkaline phosphatase level 7.037721161395893E-7
Hibadh
Hibadhtm1b(EUCOMM)Wtsi
Clinical Chemistry Alkaline phosphatase homozygote Male decreased circulating alkaline phosphatase level 7.037721161395893E-7
G3bp1
G3bp1tm1b(KOMP)Wtsi
Echo Body Temp heterozygote Female increased body temperature 7.366183467638621E-7
G3bp1
G3bp1tm1b(KOMP)Wtsi
Echo Body Temp heterozygote Male increased body temperature 7.366183467638621E-7
Camk1
Camk1tm2b(EUCOMM)Hmgu
Acoustic Startle and Pre-pulse Inhibition (PPI) % Pre-pulse inhibition - PPI3 homozygote Female decreased prepulse inhibition 7.497281444557302E-7
Col1a2
Col1a2tm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Bone Mineral Content (excluding skull) homozygote Male increased bone mineral content 7.705085067755135E-7
Bhmt
Bhmttm1b(EUCOMM)Hmgu
Body Composition (DEXA lean/fat) Fat/Body weight homozygote Male decreased total body fat amount 7.728978630439087E-7
Slc44a1
Slc44a1tm1b(EUCOMM)Hmgu
Body Composition (DEXA lean/fat) Fat mass homozygote Female decreased total body fat amount 8.719839570403565E-7
Slc44a1
Slc44a1tm1b(EUCOMM)Hmgu
Body Composition (DEXA lean/fat) Fat mass homozygote Male decreased total body fat amount 8.719839570403565E-7
Sirpa
Sirpatm1b(EUCOMM)Hmgu
Intraperitoneal glucose tolerance test (IPGTT) Initial response to glucose challenge homozygote Female impaired glucose tolerance 8.945668810156349E-7
Col1a2
Col1a2tm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Bone Mineral Density (excluding skull) homozygote Female increased bone mineral density 9.013836574922607E-7
Col1a2
Col1a2tm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Bone Mineral Density (excluding skull) homozygote Male increased bone mineral density 9.013836574922607E-7
Smo
Smotm1b(KOMP)Wtsi
Electrocardiogram (ECG) HRV heterozygote Female increased heart rate variability 9.338289146398893E-7
Smo
Smotm1b(KOMP)Wtsi
Electrocardiogram (ECG) HRV heterozygote Male increased heart rate variability 9.338289146398893E-7
Pfkfb1
Pfkfb1tm1b(KOMP)Wtsi
Intraperitoneal glucose tolerance test (IPGTT) Area under glucose response curve hemizygote Male impaired glucose tolerance 9.719384479467408E-7
Tmem132a
Tmem132atm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Bone Mineral Content (excluding skull) heterozygote Female decreased bone mineral content 1.060774820871302E-6
Tmem132a
Tmem132atm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Bone Mineral Content (excluding skull) heterozygote Male decreased bone mineral content 1.060774820871302E-6
Prdm14
Prdm14em2Bay
Body Composition (DEXA lean/fat) Lean/Body weight homozygote Female decreased lean body mass 1.0668380809875089E-6
Gpr68
Gpr68em2Bay
Clinical Chemistry Sodium homozygote Female increased circulating sodium level 1.0674131090127048E-6
Gpr68
Gpr68em2Bay
Clinical Chemistry Sodium homozygote Male increased circulating sodium level 1.0674131090127048E-6
Iqsec3
Iqsec3tm3b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Body length homozygote Male decreased body length 1.101807697523327E-6
Foxj3
Foxj3tm1b(EUCOMM)Wtsi
Hematology White blood cell count heterozygote Male increased leukocyte cell number 1.143096710620739E-6
Nr1d1
Nr1d1tm1(KOMP)Vlcg
Body Composition (DEXA lean/fat) Bone Mineral Content (excluding skull) homozygote Female increased bone mineral content 1.1647648534562904E-6
Nr1d1
Nr1d1tm1(KOMP)Vlcg
Body Composition (DEXA lean/fat) Bone Mineral Content (excluding skull) homozygote Male increased bone mineral content 1.1647648534562904E-6
Nr1d1
Nr1d1tm1(KOMP)Vlcg
Body Composition (DEXA lean/fat) Bone Mineral Content (excluding skull) heterozygote Female increased bone mineral content 1.1647648534562904E-6
Nr1d1
Nr1d1tm1(KOMP)Vlcg
Body Composition (DEXA lean/fat) Bone Mineral Content (excluding skull) heterozygote Male increased bone mineral content 1.1647648534562904E-6
Clybl
Clybltm1b(EUCOMM)Hmgu
Open Field Latency to center entry homozygote Male abnormal behavior 1.19549656574236E-6
Pptc7
Pptc7tm1b(EUCOMM)Hmgu
Echo Body Temp heterozygote Male increased body temperature 1.3205851701059146E-6
Rnf10
Rnf10em2Bay
Echo Body Temp homozygote Female increased body temperature 1.386811391057563E-6
Rnf10
Rnf10em2Bay
Echo Body Temp homozygote Male increased body temperature 1.386811391057563E-6
Col14a1
Col14a1tm1b(KOMP)Wtsi
Intraperitoneal glucose tolerance test (IPGTT) Area under glucose response curve homozygote Male impaired glucose tolerance 1.429105850547785E-6
Ap4e1
Ap4e1tm1b(KOMP)Wtsi
Echo HR homozygote Female decreased heart rate 1.5189120858849492E-6
Foxj3
Foxj3tm1b(EUCOMM)Wtsi
Combined SHIRPA and Dysmorphology Skin color - tail heterozygote Female abnormal skin coloration 1.6670850300215534E-6
Hyal4
Hyal4tm2b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Fat/Body weight homozygote Female decreased total body fat amount 1.7121981272794073E-6
Hyal4
Hyal4tm2b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Fat/Body weight homozygote Male decreased total body fat amount 1.7121981272794073E-6
Tnpo2
Tnpo2tm1b(EUCOMM)Hmgu
Echo Body Temp homozygote Female increased body temperature 1.7805884908739245E-6
Tnpo2
Tnpo2tm1b(EUCOMM)Hmgu
Echo Body Temp homozygote Male increased body temperature 1.7805884908739245E-6
Patl1
Patl1tm1b(EUCOMM)Wtsi
Acoustic Startle and Pre-pulse Inhibition (PPI) % Pre-pulse inhibition - PPI3 heterozygote Female decreased prepulse inhibition 1.9008920162377763E-6
Tmem132a
Tmem132atm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Fat mass heterozygote Male increased total body fat amount 1.909880666062236E-6
Nr1d1
Nr1d1tm1(KOMP)Vlcg
Echo LVAWs homozygote Female thin ventricular wall 1.976147359528113E-6
Nr1d1
Nr1d1tm1(KOMP)Vlcg
Echo LVAWs homozygote Male thin ventricular wall 1.976147359528113E-6
Arhgap33
Arhgap33tm1b(KOMP)Wtsi
Electrocardiogram (ECG) PQ heterozygote Female prolonged PQ interval 2.028837116085924E-6
Arhgap33
Arhgap33tm1b(KOMP)Wtsi
Electrocardiogram (ECG) PQ heterozygote Male prolonged PQ interval 2.028837116085924E-6
Col1a2
Col1a2tm1b(EUCOMM)Wtsi
Echo End-Systolic Diameter homozygote Female dilated heart left ventricle 2.1347666461224435E-6
Col1a2
Col1a2tm1b(EUCOMM)Wtsi
Echo End-Systolic Diameter homozygote Male dilated heart left ventricle 2.1347666461224435E-6
Gpr61
Gpr61em1Bay
Body Composition (DEXA lean/fat) Bone Mineral Content (excluding skull) homozygote Female decreased bone mineral content 2.1809541976836044E-6
Gpr61
Gpr61em1Bay
Body Composition (DEXA lean/fat) Bone Mineral Content (excluding skull) homozygote Male decreased bone mineral content 2.1809541976836044E-6
Slc44a1
Slc44a1tm1b(EUCOMM)Hmgu
Body Composition (DEXA lean/fat) Bone Mineral Content (excluding skull) homozygote Female increased bone mineral content 2.2523415736941388E-6
Slc44a1
Slc44a1tm1b(EUCOMM)Hmgu
Body Composition (DEXA lean/fat) Bone Mineral Content (excluding skull) homozygote Male increased bone mineral content 2.2523415736941388E-6
Foxj3
Foxj3tm1b(EUCOMM)Wtsi
Combined SHIRPA and Dysmorphology Coat - hair distribution - abdomen heterozygote Male abnormal coat/ hair morphology 2.25670510189957E-6
Dact2
Dact2tm1b(EUCOMM)Wtsi
Combined SHIRPA and Dysmorphology Coat - hair distribution - abdomen homozygote Male abnormal coat/ hair morphology 2.25670510189957E-6
Bhmt
Bhmttm1b(EUCOMM)Hmgu
Body Composition (DEXA lean/fat) Lean/Body weight homozygote Male increased lean body mass 2.3411353140545543E-6
Smco2
Smco2tm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Fat/Body weight homozygote Male decreased total body fat amount 2.4848463908710983E-6
Dnah1
Dnah1tm1b(EUCOMM)Hmgu
Clinical Chemistry Alkaline phosphatase homozygote Female decreased circulating alkaline phosphatase level 2.5269882826250978E-6
Dnah1
Dnah1tm1b(EUCOMM)Hmgu
Clinical Chemistry Alkaline phosphatase homozygote Male decreased circulating alkaline phosphatase level 2.5269882826250978E-6
Pptc7
Pptc7tm1b(EUCOMM)Hmgu
Combined SHIRPA and Dysmorphology Coat - hair texture / appearance - abdomen homozygote Male abnormal coat appearance 2.559828999437741E-6
Pptc7
Pptc7tm1b(EUCOMM)Hmgu
Combined SHIRPA and Dysmorphology Coat - hair texture / appearance - abdomen heterozygote Male abnormal coat appearance 2.559828999437741E-6
Gpr61
Gpr61em1Bay
Heart Weight Heart weight homozygote Female decreased heart weight 2.6697400699049467E-6
Gpr61
Gpr61em1Bay
Heart Weight Heart weight homozygote Male decreased heart weight 2.6697400699049467E-6
Sirpa
Sirpatm1b(EUCOMM)Hmgu
Body Composition (DEXA lean/fat) Lean/Body weight homozygote Male increased lean body mass 2.751917236309964E-6
Slc44a1
Slc44a1tm1b(EUCOMM)Hmgu
Body Composition (DEXA lean/fat) BMC/Body weight homozygote Female increased bone mineral content 2.783758418445359E-6
Slc44a1
Slc44a1tm1b(EUCOMM)Hmgu
Body Composition (DEXA lean/fat) BMC/Body weight homozygote Male increased bone mineral content 2.783758418445359E-6
Prdm14
Prdm14tm1a(EUCOMM)Wtsi
Indirect Calorimetry Respiratory Exchange Ratio homozygote Male decreased respiratory quotient 3.079776888625929E-6
Fbxl16
Fbxl16tm1b(KOMP)Wtsi
Acoustic Startle and Pre-pulse Inhibition (PPI) % Pre-pulse inhibition - PPI3 heterozygote Female increased prepulse inhibition 3.2407242542831227E-6
Fbxl16
Fbxl16tm1b(KOMP)Wtsi
Acoustic Startle and Pre-pulse Inhibition (PPI) % Pre-pulse inhibition - PPI3 heterozygote Male increased prepulse inhibition 3.2407242542831227E-6
Fgfr4
Fgfr4tm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Body length homozygote Male increased body length 3.325533953102422E-6
Fgfr4
Fgfr4tm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Body length heterozygote Male increased body length 3.325533953102422E-6
Tarbp1
Tarbp1tm1b(EUCOMM)Hmgu
Combined SHIRPA and Dysmorphology Skin color - tail homozygote Female abnormal skin coloration 3.5839339034282602E-6
Serpinf1
Serpinf1tm1e.1(KOMP)Wtsi
Echo Body Temp homozygote Female decreased body temperature 3.6856420138065005E-6
Serpinf1
Serpinf1tm1e.1(KOMP)Wtsi
Echo Body Temp homozygote Male decreased body temperature 3.6856420138065005E-6
Serpinf1
Serpinf1tm1e.1(KOMP)Wtsi
Echo Body Temp heterozygote Female decreased body temperature 3.6856420138065005E-6
Serpinf1
Serpinf1tm1e.1(KOMP)Wtsi
Echo Body Temp heterozygote Male decreased body temperature 3.6856420138065005E-6
Prdm14
Prdm14tm1a(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Lean mass homozygote Female decreased lean body mass 3.798503257712582E-6
Erg
Ergem1Bay
Hematology White blood cell count heterozygote Female decreased leukocyte cell number 3.917768481187522E-6
Erg
Ergem1Bay
Hematology White blood cell count heterozygote Male decreased leukocyte cell number 3.917768481187522E-6
Tbc1d24
Tbc1d24tm1b(EUCOMM)Hmgu
Acoustic Startle and Pre-pulse Inhibition (PPI) % Pre-pulse inhibition - PPI1 homozygote Female abnormal sensory capabilities/reflexes/nociception 4.063328560732771E-6
Tbc1d24
Tbc1d24tm1b(EUCOMM)Hmgu
Acoustic Startle and Pre-pulse Inhibition (PPI) % Pre-pulse inhibition - PPI1 homozygote Male abnormal sensory capabilities/reflexes/nociception 4.063328560732771E-6
Slc44a1
Slc44a1tm1b(EUCOMM)Hmgu
Acoustic Startle and Pre-pulse Inhibition (PPI) Response amplitude - S homozygote Female decreased startle reflex 4.138125405006576E-6
Slc44a1
Slc44a1tm1b(EUCOMM)Hmgu
Acoustic Startle and Pre-pulse Inhibition (PPI) Response amplitude - S homozygote Male decreased startle reflex 4.138125405006576E-6
Erg
Ergem1Bay
Hematology Red blood cell count heterozygote Female increased erythrocyte cell number 4.169837666267995E-6
Erg
Ergem1Bay
Hematology Red blood cell count heterozygote Male increased erythrocyte cell number 4.169837666267995E-6
Mapkap1
Mapkap1tm1b(EUCOMM)Wtsi
Echo End-Diastolic Diameter heterozygote Female dilated heart left ventricle 4.192162123217713E-6
Mapkap1
Mapkap1tm1b(EUCOMM)Wtsi
Echo End-Diastolic Diameter heterozygote Male dilated heart left ventricle 4.192162123217713E-6
Spidr
Spidrtm1b(EUCOMM)Hmgu
Body Composition (DEXA lean/fat) Fat mass homozygote Female increased total body fat amount 4.753474968310911E-6
Spidr
Spidrtm1b(EUCOMM)Hmgu
Body Composition (DEXA lean/fat) Fat mass homozygote Male increased total body fat amount 4.753474968310911E-6
Ublcp1
Ublcp1tm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Bone Area heterozygote Female abnormal bone structure 4.794866072188597E-6
Ublcp1
Ublcp1tm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Bone Area heterozygote Male abnormal bone structure 4.794866072188597E-6
Ublcp1
Ublcp1tm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Bone Area homozygote Female abnormal bone structure 4.794866072188597E-6
Ublcp1
Ublcp1tm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Bone Area homozygote Male abnormal bone structure 4.794866072188597E-6
Dbn1
Dbn1tm1b(KOMP)Wtsi
Heart Weight Heart weight heterozygote Male increased heart weight 4.954390988132218E-6
Patl1
Patl1tm1b(EUCOMM)Wtsi
Intraperitoneal glucose tolerance test (IPGTT) Fasted blood glucose concentration heterozygote Male decreased fasted circulating glucose level 4.9595355449127965E-6
Ap4e1
Ap4e1tm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Fat mass homozygote Male decreased total body fat amount 5.059074283053633E-6
Arhgap23
Arhgap23tm1b(EUCOMM)Wtsi
Acoustic Startle and Pre-pulse Inhibition (PPI) % Pre-pulse inhibition - PPI2 homozygote Female increased prepulse inhibition 5.303541001921985E-6
Arhgap23
Arhgap23tm1b(EUCOMM)Wtsi
Acoustic Startle and Pre-pulse Inhibition (PPI) % Pre-pulse inhibition - PPI2 homozygote Male increased prepulse inhibition 5.303541001921985E-6
Smco2
Smco2tm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Lean/Body weight homozygote Female increased lean body mass 5.417846750788158E-6
Smco2
Smco2tm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Lean/Body weight homozygote Male increased lean body mass 5.417846750788158E-6
Foxj3
Foxj3tm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Fat/Body weight heterozygote Female decreased total body fat amount 5.460766715259524E-6
Foxj3
Foxj3tm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Fat/Body weight heterozygote Male decreased total body fat amount 5.460766715259524E-6
4931422A03Rik
4931422A03Riktm1b(EUCOMM)Wtsi
Echo Body Temp homozygote Female increased body temperature 5.591507488134084E-6
4931422A03Rik
4931422A03Riktm1b(EUCOMM)Wtsi
Echo Body Temp homozygote Male increased body temperature 5.591507488134084E-6
Kars
Karstm2b(EUCOMM)Hmgu
Body Composition (DEXA lean/fat) Fat mass heterozygote Female decreased total body fat amount 5.658464942825958E-6
Kars
Karstm2b(EUCOMM)Hmgu
Body Composition (DEXA lean/fat) Fat mass heterozygote Male decreased total body fat amount 5.658464942825958E-6
Abhd8
Abhd8tm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Body length homozygote Female decreased body length 5.662649527948815E-6
Ap4e1
Ap4e1tm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Lean/Body weight homozygote Male increased lean body mass 5.768446953879902E-6
Mapkap1
Mapkap1tm1b(EUCOMM)Wtsi
Echo LVIDs heterozygote Female dilated heart left ventricle 6.027239578543231E-6
Mapkap1
Mapkap1tm1b(EUCOMM)Wtsi
Echo LVIDs heterozygote Male dilated heart left ventricle 6.027239578543231E-6
Prdm14
Prdm14em2Bay
Body Composition (DEXA lean/fat) Lean mass homozygote Female decreased lean body mass 6.321142791421153E-6
Abca13
Abca13tm1b(EUCOMM)Wtsi
Combined SHIRPA and Dysmorphology Genitalia - morphology homozygote Male abnormal male genitalia morphology 6.42284703644691E-6
Foxj3
Foxj3tm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Bone Area heterozygote Male abnormal bone structure 7.113801984814927E-6
Dgcr2
Dgcr2tm1b(EUCOMM)Wtsi
Intraperitoneal glucose tolerance test (IPGTT) Area under glucose response curve homozygote Female impaired glucose tolerance 7.161190296756104E-6
Dgcr2
Dgcr2tm1b(EUCOMM)Wtsi
Intraperitoneal glucose tolerance test (IPGTT) Area under glucose response curve homozygote Male impaired glucose tolerance 7.161190296756104E-6
Ctdspl2
Ctdspl2tm2b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Lean mass heterozygote Male increased lean body mass 7.735889084869996E-6
Ctdspl2
Ctdspl2tm2b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Lean mass homozygote Male increased lean body mass 7.735889084869996E-6
Aldoa
Aldoatm1.1(KOMP)Wtsi
Echo Body Temp heterozygote Female increased body temperature 7.753015779599082E-6
Dhx40
Dhx40tm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Lean mass homozygote Male increased lean body mass 8.273074854514562E-6
Alg10b
Alg10btm1.1(KOMP)Vlcg
Body Composition (DEXA lean/fat) Fat mass heterozygote Male decreased total body fat amount 8.586937838117592E-6
Alg10b
Alg10btm1.1(KOMP)Vlcg
Body Composition (DEXA lean/fat) Fat mass homozygote Male decreased total body fat amount 8.586937838117592E-6
Gstcd
Gstcdtm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Lean/Body weight homozygote Female decreased lean body mass 9.389053957420401E-6
Smco2
Smco2tm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Fat mass homozygote Female decreased total body fat amount 1.0261357601848431E-5
Smco2
Smco2tm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Fat mass homozygote Male decreased total body fat amount 1.0261357601848431E-5
Prdm14
Prdm14tm1a(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Bone Area homozygote Female abnormal bone structure 1.0427515917399433E-5
Fbxo31
Fbxo31tm1b(EUCOMM)Wtsi
Intraperitoneal glucose tolerance test (IPGTT) Area under glucose response curve homozygote Male impaired glucose tolerance 1.0462514183018357E-5
Dbn1
Dbn1tm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Bone Area heterozygote Male abnormal bone structure 1.065415381162893E-5
Spidr
Spidrtm1b(EUCOMM)Hmgu
Body Composition (DEXA lean/fat) Lean/Body weight homozygote Female decreased lean body mass 1.0696977369661909E-5
Spidr
Spidrtm1b(EUCOMM)Hmgu
Body Composition (DEXA lean/fat) Lean/Body weight homozygote Male decreased lean body mass 1.0696977369661909E-5
Prdm14
Prdm14tm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Lean/Body weight homozygote Female decreased lean body mass 1.0869352081499528E-5
Prdm14
Prdm14tm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Lean/Body weight homozygote Male decreased lean body mass 1.0869352081499528E-5
Aldob
Aldobtm2b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Body length homozygote Female decreased body length 1.0989037946274038E-5
Aldob
Aldobtm2b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Body length homozygote Male decreased body length 1.0989037946274038E-5
Prdm14
Prdm14tm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Lean mass homozygote Female decreased lean body mass 1.1030800123990048E-5
Prdm14
Prdm14tm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Lean mass homozygote Male decreased lean body mass 1.1030800123990048E-5
Dsg2
Dsg2tm1b(EUCOMM)Wtsi
Echo Ejection Fraction homozygote Female decreased cardiac muscle contractility 1.1368986633897293E-5
Dsg2
Dsg2tm1b(EUCOMM)Wtsi
Echo Ejection Fraction homozygote Male decreased cardiac muscle contractility 1.1368986633897293E-5
Dsg2
Dsg2tm1b(EUCOMM)Wtsi
Echo Ejection Fraction heterozygote Female decreased cardiac muscle contractility 1.1368986633897293E-5
Dsg2
Dsg2tm1b(EUCOMM)Wtsi
Echo Ejection Fraction heterozygote Male decreased cardiac muscle contractility 1.1368986633897293E-5
Rnf10
Rnf10tm1b(KOMP)Wtsi
Grip Strength Forelimb grip strength measurement mean homozygote Female decreased grip strength 1.1877862561959773E-5
Rnf10
Rnf10tm1b(KOMP)Wtsi
Grip Strength Forelimb grip strength measurement mean homozygote Male decreased grip strength 1.1877862561959773E-5
Clybl
Clybltm1b(EUCOMM)Hmgu
Acoustic Startle and Pre-pulse Inhibition (PPI) % Pre-pulse inhibition - PPI3 homozygote Female increased prepulse inhibition 1.2203902770124841E-5
Clybl
Clybltm1b(EUCOMM)Hmgu
Acoustic Startle and Pre-pulse Inhibition (PPI) % Pre-pulse inhibition - PPI3 homozygote Male increased prepulse inhibition 1.2203902770124841E-5
Nxn
Nxntm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Lean mass heterozygote Female decreased lean body mass 1.250651985174045E-5
Gpr25
Gpr25em2Bay
Combined SHIRPA and Dysmorphology Skin color - tail homozygote Male abnormal skin coloration 1.2721429811790586E-5
Btbd16
Btbd16tm2b(EUCOMM)Hmgu
Combined SHIRPA and Dysmorphology Skin color - tail homozygote Female abnormal skin coloration 1.31156702991575E-5
Btbd16
Btbd16tm2b(EUCOMM)Hmgu
Combined SHIRPA and Dysmorphology Skin color - tail heterozygote Female abnormal skin coloration 1.31156702991575E-5
S1pr3
S1pr3tm1b(EUCOMM)Wtsi
Combined SHIRPA and Dysmorphology Skin color - tail homozygote Female abnormal skin coloration 1.31156702991575E-5
Lamtor5
Lamtor5tm1b(EUCOMM)Hmgu
Combined SHIRPA and Dysmorphology Skin color - tail heterozygote Female abnormal skin coloration 1.31156702991575E-5
Il12rb1
Il12rb1tm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Lean/Body weight homozygote Male increased lean body mass 1.3306334949447773E-5
Nxn
Nxntm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Lean/Body weight heterozygote Female decreased lean body mass 1.3313215276866686E-5
Chd4
Chd4tm1b(EUCOMM)Wtsi
Echo Body Temp heterozygote Female increased body temperature 1.3654531358042732E-5
Tbccd1
Tbccd1tm1b(EUCOMM)Hmgu
Intraperitoneal glucose tolerance test (IPGTT) Initial response to glucose challenge homozygote Female impaired glucose tolerance 1.4240634300222155E-5
Prdm14
Prdm14tm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Fat mass homozygote Female increased total body fat amount 1.4565906894858927E-5
Nr1d1
Nr1d1tm1(KOMP)Vlcg
Echo Cardiac Output homozygote Female decreased cardiac output 1.4647324860561639E-5
Nr1d1
Nr1d1tm1(KOMP)Vlcg
Echo Cardiac Output homozygote Male decreased cardiac output 1.4647324860561639E-5
Mmp15
Mmp15tm1b(KOMP)Wtsi
Combined SHIRPA and Dysmorphology Skin color - front paws homozygote Female abnormal skin coloration 1.5052750313770957E-5
Dnase1l2
Dnase1l2em2Bay
Body Composition (DEXA lean/fat) Bone Mineral Density (excluding skull) homozygote Male decreased bone mineral density 1.6778911231085658E-5
Dsg2
Dsg2tm1b(EUCOMM)Wtsi
Echo Fractional Shortening homozygote Female decreased cardiac muscle contractility 1.7395666873198934E-5
Dsg2
Dsg2tm1b(EUCOMM)Wtsi
Echo Fractional Shortening homozygote Male decreased cardiac muscle contractility 1.7395666873198934E-5
Dsg2
Dsg2tm1b(EUCOMM)Wtsi
Echo Fractional Shortening heterozygote Female decreased cardiac muscle contractility 1.7395666873198934E-5
Dsg2
Dsg2tm1b(EUCOMM)Wtsi
Echo Fractional Shortening heterozygote Male decreased cardiac muscle contractility 1.7395666873198934E-5
Scarb1
Scarb1tm1b(EUCOMM)Wtsi
Electrocardiogram (ECG) PQ heterozygote Female prolonged PQ interval 1.7889267837745138E-5
Scarb1
Scarb1tm1b(EUCOMM)Wtsi
Electrocardiogram (ECG) PQ heterozygote Male prolonged PQ interval 1.7889267837745138E-5
Ap4e1
Ap4e1tm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Lean mass homozygote Male increased lean body mass 1.7934404240804724E-5
Ublcp1
Ublcp1tm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Bone Mineral Content (excluding skull) heterozygote Male decreased bone mineral content 1.8439874111209065E-5
Spidr
Spidrtm1b(EUCOMM)Hmgu
Body Composition (DEXA lean/fat) Bone Mineral Content (excluding skull) homozygote Female decreased bone mineral content 1.8996002836502157E-5
Kcng2
Kcng2em2Bay
Electrocardiogram (ECG) ST homozygote Female shortened ST segment 1.9318222257425077E-5
Kcng2
Kcng2em2Bay
Electrocardiogram (ECG) ST homozygote Male shortened ST segment 1.9318222257425077E-5
Slc44a1
Slc44a1tm1b(EUCOMM)Hmgu
Body Composition (DEXA lean/fat) Lean/Body weight homozygote Male increased lean body mass 1.952045022335369E-5
Ankrd7
Ankrd7tm1b(KOMP)Wtsi
Intraperitoneal glucose tolerance test (IPGTT) Initial response to glucose challenge homozygote Male improved glucose tolerance 2.0704730559373274E-5
Il3
Il3tm1.1(KOMP)Mbp
Body Composition (DEXA lean/fat) Bone Mineral Content (excluding skull) homozygote Female increased bone mineral content 2.1189409380895086E-5
Il3
Il3tm1.1(KOMP)Mbp
Body Composition (DEXA lean/fat) Bone Mineral Content (excluding skull) homozygote Male decreased bone mineral content 2.1189409380895086E-5
Pmpcb
Pmpcbtm1b(EUCOMM)Hmgu
Acoustic Startle and Pre-pulse Inhibition (PPI) % Pre-pulse inhibition - PPI1 heterozygote Female abnormal sensory capabilities/reflexes/nociception 2.1643678337568417E-5
Pmpcb
Pmpcbtm1b(EUCOMM)Hmgu
Acoustic Startle and Pre-pulse Inhibition (PPI) % Pre-pulse inhibition - PPI1 heterozygote Male abnormal sensory capabilities/reflexes/nociception 2.1643678337568417E-5
Gpr61
Gpr61em1Bay
Body Composition (DEXA lean/fat) Bone Area homozygote Female abnormal bone structure 2.1737963834311813E-5
Gpr61
Gpr61em1Bay
Body Composition (DEXA lean/fat) Bone Area homozygote Male abnormal bone structure 2.1737963834311813E-5
Il12rb1
Il12rb1tm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Lean mass homozygote Male increased lean body mass 2.1759198716608807E-5
Mthfd2
Mthfd2tm1b(EUCOMM)Wtsi
Eye Morphology Lens Opacity heterozygote Male cataract 2.2371430532075465E-5
Mthfd2
Mthfd2tm1b(EUCOMM)Wtsi
Eye Morphology Lens Opacity homozygote Male cataract 2.2371430532075465E-5
Tead1
Tead1tm1b(KOMP)Wtsi
Heart Weight Heart weight heterozygote Male increased heart weight 2.2483616703539155E-5
Tead1
Tead1tm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Bone Area heterozygote Female abnormal bone structure 2.272397978231311E-5
Tead1
Tead1tm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Bone Area heterozygote Male abnormal bone structure 2.272397978231311E-5
Rnf10
Rnf10em2Bay
Echo LVAWd homozygote Female increased heart left ventricle size 2.312103424628731E-5
Rnf10
Rnf10em2Bay
Echo LVAWd homozygote Male increased heart left ventricle size 2.312103424628731E-5
Fgfr4
Fgfr4tm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Bone Mineral Content (excluding skull) homozygote Female decreased bone mineral content 2.353740273974836E-5
Fgfr4
Fgfr4tm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Bone Mineral Content (excluding skull) homozygote Male decreased bone mineral content 2.353740273974836E-5
Fgfr4
Fgfr4tm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Bone Mineral Content (excluding skull) heterozygote Female decreased bone mineral content 2.353740273974836E-5
Fgfr4
Fgfr4tm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Bone Mineral Content (excluding skull) heterozygote Male decreased bone mineral content 2.353740273974836E-5
Hoxb13
Hoxb13tm1b(KOMP)Wtsi
Echo Body Temp heterozygote Female increased body temperature 2.3673213945585303E-5
Hoxb13
Hoxb13tm1b(KOMP)Wtsi
Echo Body Temp heterozygote Male increased body temperature 2.3673213945585303E-5
Kars
Karstm2b(EUCOMM)Hmgu
Body Composition (DEXA lean/fat) Lean mass heterozygote Male increased lean body mass 2.5404475309187546E-5
Lrrfip1
Lrrfip1tm1.1(KOMP)Wtsi
Echo Body Temp heterozygote Female increased body temperature 2.5724395527504385E-5
Lrrfip1
Lrrfip1tm1.1(KOMP)Wtsi
Echo Body Temp heterozygote Male increased body temperature 2.5724395527504385E-5
Dsg2
Dsg2tm1b(EUCOMM)Wtsi
Combined SHIRPA and Dysmorphology Coat - hair texture / appearance - abdomen heterozygote Male abnormal coat appearance 2.579017927928362E-5
Dsg2
Dsg2tm1b(EUCOMM)Wtsi
Combined SHIRPA and Dysmorphology Coat - hair texture / appearance - abdomen homozygote Male abnormal coat appearance 2.579017927928362E-5
Col1a2
Col1a2tm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Fat mass homozygote Male decreased total body fat amount 2.6353101929998957E-5
Etnk1
Etnk1tm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Body length homozygote Male increased body length 2.7951351512456313E-5
Sirpa
Sirpatm1b(EUCOMM)Hmgu
Body Composition (DEXA lean/fat) Lean mass homozygote Male increased lean body mass 2.8209231459186412E-5
Taf6
Taf6tm1b(EUCOMM)Hmgu
Body Composition (DEXA lean/fat) Lean mass heterozygote Female decreased lean body mass 2.917435995186679E-5
Taf6
Taf6tm1b(EUCOMM)Hmgu
Body Composition (DEXA lean/fat) Lean mass heterozygote Male increased lean body mass 2.917435995186679E-5
Fgfr4
Fgfr4tm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Bone Area homozygote Female abnormal bone structure 2.964424311358016E-5
Fgfr4
Fgfr4tm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Bone Area homozygote Male abnormal bone structure 2.964424311358016E-5
Fgfr4
Fgfr4tm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Bone Area heterozygote Female abnormal bone structure 2.964424311358016E-5
Fgfr4
Fgfr4tm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Bone Area heterozygote Male abnormal bone structure 2.964424311358016E-5
Rnf10
Rnf10em2Bay
Acoustic Startle and Pre-pulse Inhibition (PPI) Response amplitude - S homozygote Male decreased startle reflex 3.0889637855580077E-5
Dgcr2
Dgcr2tm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) BMC/Body weight homozygote Female increased bone mineral content 3.113835191470571E-5
Pdx1
Pdx1tm1b(EUCOMM)Wtsi
Open Field Center average speed heterozygote Female abnormal behavior 3.1716259400127456E-5
Pdx1
Pdx1tm1b(EUCOMM)Wtsi
Open Field Center average speed heterozygote Male abnormal behavior 3.1716259400127456E-5
Mapkap1
Mapkap1tm1b(EUCOMM)Wtsi
Echo LVIDd heterozygote Female dilated heart left ventricle 3.247739005018957E-5
Mapkap1
Mapkap1tm1b(EUCOMM)Wtsi
Echo LVIDd heterozygote Male dilated heart left ventricle 3.247739005018957E-5
Paqr6
Paqr6tm1b(KOMP)Wtsi
Electrocardiogram (ECG) rMSSD homozygote Female cardiovascular system phenotype 3.434637619648129E-5
Paqr6
Paqr6tm1b(KOMP)Wtsi
Electrocardiogram (ECG) rMSSD homozygote Male cardiovascular system phenotype 3.434637619648129E-5
Wdr59
Wdr59tm1b(EUCOMM)Wtsi
Intraperitoneal glucose tolerance test (IPGTT) Area under glucose response curve heterozygote Male impaired glucose tolerance 3.4891723771579564E-5
Nanos2
Nanos2em2Bay
Body Composition (DEXA lean/fat) Bone Area homozygote Male abnormal bone structure 3.539930548868142E-5
Dbn1
Dbn1tm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Fat mass heterozygote Male decreased total body fat amount 3.56404525518883E-5
Rps19bp1
Rps19bp1tm1.1(KOMP)Wtsi
Combined SHIRPA and Dysmorphology Skin color - tail heterozygote Female abnormal skin coloration 3.6012828786624596E-5
Camk1
Camk1tm2b(EUCOMM)Hmgu
Intraperitoneal glucose tolerance test (IPGTT) Fasted blood glucose concentration homozygote Female decreased fasted circulating glucose level 3.622466465458274E-5
Camk1
Camk1tm2b(EUCOMM)Hmgu
Intraperitoneal glucose tolerance test (IPGTT) Fasted blood glucose concentration homozygote Male decreased fasted circulating glucose level 3.622466465458274E-5
Mapkap1
Mapkap1tm1b(EUCOMM)Wtsi
Echo Stroke Volume heterozygote Female increased cardiac stroke volume 3.631104118539952E-5
Mapkap1
Mapkap1tm1b(EUCOMM)Wtsi
Echo Stroke Volume heterozygote Male increased cardiac stroke volume 3.631104118539952E-5
Kcng2
Kcng2em2Bay
Electrocardiogram (ECG) QTc homozygote Female shortened QT interval 3.6382934922585264E-5
Kcng2
Kcng2em2Bay
Electrocardiogram (ECG) QTc homozygote Male shortened QT interval 3.6382934922585264E-5
Dact2
Dact2tm1b(EUCOMM)Wtsi
Combined SHIRPA and Dysmorphology Skin texture - whole body homozygote Male abnormal skin morphology 3.776839002966881E-5
Col1a2
Col1a2tm1b(EUCOMM)Wtsi
Heart Weight Heart weight homozygote Female increased heart weight 3.791087874560617E-5
Col1a2
Col1a2tm1b(EUCOMM)Wtsi
Heart Weight Heart weight homozygote Male increased heart weight 3.791087874560617E-5
Dnase1l2
Dnase1l2tm1.1(KOMP)Wtsi
Body Composition (DEXA lean/fat) Body length homozygote Female decreased body length 3.80008714273572E-5
Dnase1l2
Dnase1l2tm1.1(KOMP)Wtsi
Body Composition (DEXA lean/fat) Body length heterozygote Female decreased body length 3.80008714273572E-5
Pyroxd1
Pyroxd1tm1b(KOMP)Wtsi
Combined SHIRPA and Dysmorphology Tremor heterozygote Male tremors 3.8438389310613275E-5
Scarb1
Scarb1tm1b(EUCOMM)Wtsi
Echo Fractional Shortening homozygote Female decreased cardiac muscle contractility 3.901721356669441E-5
Scarb1
Scarb1tm1b(EUCOMM)Wtsi
Echo Fractional Shortening homozygote Male decreased cardiac muscle contractility 3.901721356669441E-5
Ap4e1
Ap4e1tm1b(KOMP)Wtsi
Acoustic Startle and Pre-pulse Inhibition (PPI) % Pre-pulse inhibition - PPI2 homozygote Female increased prepulse inhibition 3.946039578295313E-5
Ap4e1
Ap4e1tm1b(KOMP)Wtsi
Acoustic Startle and Pre-pulse Inhibition (PPI) % Pre-pulse inhibition - PPI2 homozygote Male increased prepulse inhibition 3.946039578295313E-5
Ogfod3
Ogfod3tm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Bone Mineral Density (excluding skull) homozygote Female decreased bone mineral density 4.0049850213108584E-5
Ogfod3
Ogfod3tm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Bone Mineral Density (excluding skull) homozygote Male decreased bone mineral density 4.0049850213108584E-5
Ogfod3
Ogfod3tm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Bone Mineral Density (excluding skull) heterozygote Female decreased bone mineral density 4.0049850213108584E-5
Ogfod3
Ogfod3tm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Bone Mineral Density (excluding skull) heterozygote Male decreased bone mineral density 4.0049850213108584E-5
Kars
Karstm2b(EUCOMM)Hmgu
Intraperitoneal glucose tolerance test (IPGTT) Fasted blood glucose concentration heterozygote Female decreased fasted circulating glucose level 4.012963836430572E-5
Kars
Karstm2b(EUCOMM)Hmgu
Intraperitoneal glucose tolerance test (IPGTT) Fasted blood glucose concentration heterozygote Male increased fasted circulating glucose level 4.012963836430572E-5
Dst
Dsttm1b(EUCOMM)Wtsi
Clinical Chemistry Sodium heterozygote Female decreased circulating sodium level 4.059004277223721E-5
Dst
Dsttm1b(EUCOMM)Wtsi
Clinical Chemistry Sodium heterozygote Male decreased circulating sodium level 4.059004277223721E-5
Spidr
Spidrtm1b(EUCOMM)Hmgu
Body Composition (DEXA lean/fat) Lean mass homozygote Female decreased lean body mass 4.230506965541281E-5
Spidr
Spidrtm1b(EUCOMM)Hmgu
Body Composition (DEXA lean/fat) Lean mass homozygote Male decreased lean body mass 4.230506965541281E-5
Hyal4
Hyal4tm2b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Bone Area homozygote Female abnormal bone structure 4.2982024751836434E-5
Hyal4
Hyal4tm2b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Bone Area homozygote Male abnormal bone structure 4.2982024751836434E-5
Col1a2
Col1a2tm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Fat/Body weight homozygote Male decreased total body fat amount 4.299967986298725E-5
Ogfod3
Ogfod3tm1b(KOMP)Wtsi
Combined SHIRPA and Dysmorphology Trunk curl homozygote Male trunk curl 4.351073948782869E-5
Ogfod3
Ogfod3tm1b(KOMP)Wtsi
Combined SHIRPA and Dysmorphology Trunk curl heterozygote Male trunk curl 4.351073948782869E-5
Rnf38
Rnf38tm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) BMC/Body weight heterozygote Male increased bone mineral content 4.4330994569463655E-5
Rnf38
Rnf38tm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) BMC/Body weight heterozygote Female decreased bone mineral content 4.4330994569463655E-5
Spo11
Spo11tm2b(KOMP)Wtsi
Echo Body Temp homozygote Male increased body temperature 4.5569311623694375E-5
Spo11
Spo11tm2b(KOMP)Wtsi
Echo Body Temp heterozygote Male increased body temperature 4.5569311623694375E-5
Pmpcb
Pmpcbtm1b(EUCOMM)Hmgu
Acoustic Startle and Pre-pulse Inhibition (PPI) % Pre-pulse inhibition - PPI3 heterozygote Female increased prepulse inhibition 4.591349352267571E-5
Pmpcb
Pmpcbtm1b(EUCOMM)Hmgu
Acoustic Startle and Pre-pulse Inhibition (PPI) % Pre-pulse inhibition - PPI3 heterozygote Male increased prepulse inhibition 4.591349352267571E-5
Btbd16
Btbd16tm2b(EUCOMM)Hmgu
Acoustic Startle and Pre-pulse Inhibition (PPI) Response amplitude - S homozygote Female decreased startle reflex 4.691318463301286E-5
Btbd16
Btbd16tm2b(EUCOMM)Hmgu
Acoustic Startle and Pre-pulse Inhibition (PPI) Response amplitude - S homozygote Male decreased startle reflex 4.691318463301286E-5
Btbd16
Btbd16tm2b(EUCOMM)Hmgu
Acoustic Startle and Pre-pulse Inhibition (PPI) Response amplitude - S heterozygote Female decreased startle reflex 4.691318463301286E-5
Btbd16
Btbd16tm2b(EUCOMM)Hmgu
Acoustic Startle and Pre-pulse Inhibition (PPI) Response amplitude - S heterozygote Male decreased startle reflex 4.691318463301286E-5
Hibadh
Hibadhtm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Fat/Body weight homozygote Female decreased total body fat amount 4.700306453742087E-5
Hibadh
Hibadhtm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Fat/Body weight homozygote Male decreased total body fat amount 4.700306453742087E-5
Scarb1
Scarb1tm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Fat mass homozygote Male decreased total body fat amount 4.7004759835544974E-5
Slc44a1
Slc44a1tm1b(EUCOMM)Hmgu
Body Composition (DEXA lean/fat) Bone Area homozygote Female abnormal bone structure 4.7409910621354356E-5
Slc44a1
Slc44a1tm1b(EUCOMM)Hmgu
Body Composition (DEXA lean/fat) Bone Area homozygote Male abnormal bone structure 4.7409910621354356E-5
Taf6
Taf6tm1b(EUCOMM)Hmgu
Hematology Red blood cell count heterozygote Female increased erythrocyte cell number 4.9652600864646956E-5
Taf6
Taf6tm1b(EUCOMM)Hmgu
Hematology Red blood cell count heterozygote Male increased erythrocyte cell number 4.9652600864646956E-5
Nos1ap
Nos1aptm1b(KOMP)Wtsi
Heart Weight Heart weight homozygote Male increased heart weight 5.1336701289983466E-5
Map3k12
Map3k12tm1b(EUCOMM)Hmgu
Acoustic Startle and Pre-pulse Inhibition (PPI) Response amplitude - S heterozygote Male increased startle reflex 5.177691127755679E-5
Dsg2
Dsg2tm1b(EUCOMM)Wtsi
Echo End-Systolic Diameter homozygote Female dilated heart left ventricle 5.322135621099733E-5
Dsg2
Dsg2tm1b(EUCOMM)Wtsi
Echo End-Systolic Diameter homozygote Male dilated heart left ventricle 5.322135621099733E-5
Dsg2
Dsg2tm1b(EUCOMM)Wtsi
Echo End-Systolic Diameter heterozygote Female dilated heart left ventricle 5.322135621099733E-5
Dsg2
Dsg2tm1b(EUCOMM)Wtsi
Echo End-Systolic Diameter heterozygote Male dilated heart left ventricle 5.322135621099733E-5
Pptc7
Pptc7tm1b(EUCOMM)Hmgu
Body Composition (DEXA lean/fat) Bone Mineral Density (excluding skull) heterozygote Female increased bone mineral density 5.3243860747898E-5
Pptc7
Pptc7tm1b(EUCOMM)Hmgu
Body Composition (DEXA lean/fat) Bone Mineral Density (excluding skull) heterozygote Male increased bone mineral density 5.3243860747898E-5
Pptc7
Pptc7tm1b(EUCOMM)Hmgu
Body Composition (DEXA lean/fat) Bone Mineral Density (excluding skull) homozygote Female increased bone mineral density 5.3243860747898E-5
Pptc7
Pptc7tm1b(EUCOMM)Hmgu
Body Composition (DEXA lean/fat) Bone Mineral Density (excluding skull) homozygote Male increased bone mineral density 5.3243860747898E-5
Foxj3
Foxj3tm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Bone Mineral Content (excluding skull) heterozygote Male increased bone mineral content 5.327224062057212E-5
Gstcd
Gstcdtm1b(EUCOMM)Wtsi
Acoustic Startle and Pre-pulse Inhibition (PPI) Response amplitude - S homozygote Female decreased startle reflex 5.3310512157622725E-5
Gstcd
Gstcdtm1b(EUCOMM)Wtsi
Acoustic Startle and Pre-pulse Inhibition (PPI) Response amplitude - S homozygote Male decreased startle reflex 5.3310512157622725E-5
Zfpl1
Zfpl1tm2b(EUCOMM)Wtsi
Acoustic Startle and Pre-pulse Inhibition (PPI) Response amplitude - S homozygote Female increased startle reflex 5.377693742047995E-5
Zfpl1
Zfpl1tm2b(EUCOMM)Wtsi
Acoustic Startle and Pre-pulse Inhibition (PPI) Response amplitude - S homozygote Male increased startle reflex 5.377693742047995E-5
Nanos2
Nanos2em2Bay
Body Composition (DEXA lean/fat) Bone Mineral Content (excluding skull) homozygote Male increased bone mineral content 5.388349018176086E-5
Prkab1
Prkab1tm1b(KOMP)Wtsi
Intraperitoneal glucose tolerance test (IPGTT) Area under glucose response curve homozygote Female impaired glucose tolerance 5.470552059705369E-5
Prkab1
Prkab1tm1b(KOMP)Wtsi
Intraperitoneal glucose tolerance test (IPGTT) Area under glucose response curve homozygote Male impaired glucose tolerance 5.470552059705369E-5
Arhgap33
Arhgap33tm1b(KOMP)Wtsi
Electrocardiogram (ECG) PR heterozygote Female prolonged PR interval 5.5062111641746014E-5
Arhgap33
Arhgap33tm1b(KOMP)Wtsi
Electrocardiogram (ECG) PR heterozygote Male prolonged PR interval 5.5062111641746014E-5
Fbxl16
Fbxl16tm1b(KOMP)Wtsi
Echo HR heterozygote Female increased heart rate 5.6069573474815115E-5
Fbxl16
Fbxl16tm1b(KOMP)Wtsi
Echo HR heterozygote Male decreased heart rate 5.6069573474815115E-5
0610009B22Rik
0610009B22Riktm1b(EUCOMM)Hmgu
Acoustic Startle and Pre-pulse Inhibition (PPI) Response amplitude - S homozygote Female decreased startle reflex 5.679464811692014E-5
0610009B22Rik
0610009B22Riktm1b(EUCOMM)Hmgu
Acoustic Startle and Pre-pulse Inhibition (PPI) Response amplitude - S homozygote Male decreased startle reflex 5.679464811692014E-5
0610009B22Rik
0610009B22Riktm1b(EUCOMM)Hmgu
Acoustic Startle and Pre-pulse Inhibition (PPI) Response amplitude - S heterozygote Female decreased startle reflex 5.679464811692014E-5
0610009B22Rik
0610009B22Riktm1b(EUCOMM)Hmgu
Acoustic Startle and Pre-pulse Inhibition (PPI) Response amplitude - S heterozygote Male decreased startle reflex 5.679464811692014E-5
Cldn12
Cldn12tm1b(EUCOMM)Wtsi
Intraperitoneal glucose tolerance test (IPGTT) Initial response to glucose challenge homozygote Female improved glucose tolerance 5.693636921932921E-5
Cldn12
Cldn12tm1b(EUCOMM)Wtsi
Intraperitoneal glucose tolerance test (IPGTT) Initial response to glucose challenge homozygote Male improved glucose tolerance 5.693636921932921E-5
Cldn12
Cldn12tm1b(EUCOMM)Wtsi
Intraperitoneal glucose tolerance test (IPGTT) Initial response to glucose challenge heterozygote Female improved glucose tolerance 5.693636921932921E-5
Cldn12
Cldn12tm1b(EUCOMM)Wtsi
Intraperitoneal glucose tolerance test (IPGTT) Initial response to glucose challenge heterozygote Male improved glucose tolerance 5.693636921932921E-5
Tfeb
Tfebtm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Fat mass heterozygote Female increased total body fat amount 5.910822073929012E-5
Tfeb
Tfebtm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Fat mass heterozygote Male increased total body fat amount 5.910822073929012E-5
Tead1
Tead1tm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Bone Mineral Content (excluding skull) heterozygote Male increased bone mineral content 5.9163739933865145E-5
Tead1
Tead1tm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Bone Mineral Content (excluding skull) heterozygote Female decreased bone mineral content 5.9163739933865145E-5
Ankrd7
Ankrd7tm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Bone Area homozygote Male abnormal bone structure 5.9293259255355224E-5
Mmp15
Mmp15tm1b(KOMP)Wtsi
Combined SHIRPA and Dysmorphology Skin color - back paws homozygote Female abnormal skin coloration 5.9335361584089696E-5
Tead1
Tead1tm1b(KOMP)Wtsi
Echo End-Diastolic Diameter heterozygote Male dilated heart left ventricle 5.938716640230268E-5
Tead1
Tead1tm1b(KOMP)Wtsi
Echo End-Diastolic Diameter heterozygote Female abnormal heart left ventricle morphology 5.938716640230268E-5
Rrm2
Rrm2tm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) BMC/Body weight heterozygote Female increased bone mineral content 5.9873687860090286E-5
Scarb1
Scarb1tm1b(EUCOMM)Wtsi
Electrocardiogram (ECG) QTc heterozygote Female prolonged QT interval 6.102303814259358E-5
Dnase1l2
Dnase1l2em2Bay
Body Composition (DEXA lean/fat) Bone Mineral Content (excluding skull) homozygote Female increased bone mineral content 6.118872988736257E-5
Dnase1l2
Dnase1l2em2Bay
Body Composition (DEXA lean/fat) Bone Mineral Content (excluding skull) homozygote Male decreased bone mineral content 6.118872988736257E-5
Ctdspl2
Ctdspl2tm2b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Lean/Body weight heterozygote Male increased lean body mass 6.411023787222803E-5
Ctdspl2
Ctdspl2tm2b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Lean/Body weight homozygote Male increased lean body mass 6.411023787222803E-5
Dnah1
Dnah1tm1b(EUCOMM)Hmgu
Combined SHIRPA and Dysmorphology Coat - hair texture / appearance - abdomen homozygote Male abnormal coat appearance 6.450741784647107E-5
Slc44a1
Slc44a1tm1b(EUCOMM)Hmgu
Combined SHIRPA and Dysmorphology Coat - hair texture / appearance - abdomen homozygote Male abnormal coat appearance 6.450741784647107E-5
Dhx40
Dhx40tm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Lean/Body weight homozygote Male increased lean body mass 6.488784856628627E-5
Acat2
Acat2tm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Body length heterozygote Female increased body length 6.643752567470074E-5
Acat2
Acat2tm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Body length heterozygote Male increased body length 6.643752567470074E-5
Rrm2
Rrm2tm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Lean mass heterozygote Male decreased lean body mass 6.712949834764004E-5
Pdx1
Pdx1tm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Bone Mineral Density (excluding skull) heterozygote Female decreased bone mineral density 6.814485095674172E-5
Pdx1
Pdx1tm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Bone Mineral Density (excluding skull) heterozygote Male decreased bone mineral density 6.814485095674172E-5
Dsg2
Dsg2tm1b(EUCOMM)Wtsi
Heart Weight Heart weight homozygote Female increased heart weight 7.106424163794145E-5
Dsg2
Dsg2tm1b(EUCOMM)Wtsi
Heart Weight Heart weight heterozygote Female increased heart weight 7.106424163794145E-5
Tfeb
Tfebtm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Lean mass heterozygote Female decreased lean body mass 7.14638372301124E-5
Tfeb
Tfebtm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Lean mass heterozygote Male decreased lean body mass 7.14638372301124E-5
Rnf10
Rnf10tm1b(KOMP)Wtsi
Echo LVPWd homozygote Female thick ventricular wall 7.185103459050879E-5
Rnf10
Rnf10tm1b(KOMP)Wtsi
Echo LVPWd homozygote Male thick ventricular wall 7.185103459050879E-5
Ascc2
Ascc2tm1a(EUCOMM)Wtsi
Intraperitoneal glucose tolerance test (IPGTT) Area under glucose response curve heterozygote Female improved glucose tolerance 7.434310828102753E-5
Ascc2
Ascc2tm1a(EUCOMM)Wtsi
Intraperitoneal glucose tolerance test (IPGTT) Area under glucose response curve heterozygote Male improved glucose tolerance 7.434310828102753E-5
Tspyl2
Tspyl2tm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Fat mass hemizygote Male increased total body fat amount 7.528351852670312E-5
Dbn1
Dbn1em1Bay
Combined SHIRPA and Dysmorphology Coat - hair texture / appearance - back homozygote Male abnormal coat appearance 7.918517076177523E-5
Cox5b
Cox5btm2b(EUCOMM)Hmgu
Combined SHIRPA and Dysmorphology Skin color - tail heterozygote Male abnormal skin coloration 8.007208816707134E-5
Aldob
Aldobtm2b(EUCOMM)Wtsi
Electrocardiogram (ECG) QTc Dispersion homozygote Female abnormal QT variability 8.051768963923678E-5
Aldob
Aldobtm2b(EUCOMM)Wtsi
Electrocardiogram (ECG) QTc Dispersion homozygote Male abnormal QT variability 8.051768963923678E-5
Ublcp1
Ublcp1tm1b(KOMP)Wtsi
Combined SHIRPA and Dysmorphology Tremor homozygote Female tremors 8.18846165202558E-5
Ublcp1
Ublcp1tm1b(KOMP)Wtsi
Combined SHIRPA and Dysmorphology Tremor heterozygote Female tremors 8.18846165202558E-5
Aldoa
Aldoatm1.1(KOMP)Wtsi
Electrocardiogram (ECG) QTc Dispersion heterozygote Female abnormal QT variability 8.32674340927042E-5
Tspyl2
Tspyl2tm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Lean/Body weight hemizygote Male decreased lean body mass 8.438943768851459E-5
Slc44a1
Slc44a1tm1b(EUCOMM)Hmgu
Echo HR homozygote Female increased heart rate 8.577226253692061E-5
Slc44a1
Slc44a1tm1b(EUCOMM)Hmgu
Echo HR homozygote Male increased heart rate 8.577226253692061E-5
Hyal4
Hyal4tm2b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Fat mass homozygote Female decreased total body fat amount 8.599172724643722E-5
Hyal4
Hyal4tm2b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Fat mass homozygote Male decreased total body fat amount 8.599172724643722E-5
Adsl
Adsltm1b(KOMP)Wtsi
Intraperitoneal glucose tolerance test (IPGTT) Area under glucose response curve heterozygote Female impaired glucose tolerance 8.599778811912984E-5
Adsl
Adsltm1b(KOMP)Wtsi
Intraperitoneal glucose tolerance test (IPGTT) Area under glucose response curve heterozygote Male impaired glucose tolerance 8.599778811912984E-5
Kars
Karstm2b(EUCOMM)Hmgu
Intraperitoneal glucose tolerance test (IPGTT) Area under glucose response curve heterozygote Female impaired glucose tolerance 8.714714931556955E-5
Kars
Karstm2b(EUCOMM)Hmgu
Intraperitoneal glucose tolerance test (IPGTT) Area under glucose response curve heterozygote Male impaired glucose tolerance 8.714714931556955E-5
Alg10b
Alg10btm1.1(KOMP)Vlcg
Body Composition (DEXA lean/fat) Fat/Body weight heterozygote Male decreased total body fat amount 8.767318649915978E-5
Alg10b
Alg10btm1.1(KOMP)Vlcg
Body Composition (DEXA lean/fat) Fat/Body weight homozygote Male decreased total body fat amount 8.767318649915978E-5
Fbxw9
Fbxw9tm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Bone Mineral Content (excluding skull) homozygote Female increased bone mineral content 9.028502245200798E-5
Fbxw9
Fbxw9tm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Bone Mineral Content (excluding skull) homozygote Male increased bone mineral content 9.028502245200798E-5
Foxj3
Foxj3tm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) BMC/Body weight heterozygote Female increased bone mineral content 9.078210132429376E-5
Foxj3
Foxj3tm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) BMC/Body weight heterozygote Male increased bone mineral content 9.078210132429376E-5
Hyal4
Hyal4tm2b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Bone Mineral Content (excluding skull) homozygote Female increased bone mineral content 9.201814100379124E-5
Hyal4
Hyal4tm2b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Bone Mineral Content (excluding skull) homozygote Male increased bone mineral content 9.201814100379124E-5
Axin2
Axin2tm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Body length heterozygote Female decreased body length 9.336177754448727E-5
Axin2
Axin2tm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Body length heterozygote Male decreased body length 9.336177754448727E-5
Pja2
Pja2tm1b(EUCOMM)Wtsi
Electrocardiogram (ECG) HR homozygote Female increased heart rate 9.443713497603312E-5
Pja2
Pja2tm1b(EUCOMM)Wtsi
Electrocardiogram (ECG) HR homozygote Male increased heart rate 9.443713497603312E-5
Cspg4
Cspg4tm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Lean/Body weight homozygote Female increased lean body mass 9.646930266171694E-5
Cspg4
Cspg4tm1b(KOMP)Wtsi
Body Composition (DEXA lean/fat) Lean/Body weight homozygote Male increased lean body mass 9.646930266171694E-5
Ism2
Ism2tm3b(EUCOMM)Hmgu
Electrocardiogram (ECG) HRV homozygote Female decreased heart rate variability 9.79562391876243E-5
Ism2
Ism2tm3b(EUCOMM)Hmgu
Electrocardiogram (ECG) HRV homozygote Male decreased heart rate variability 9.79562391876243E-5
Btbd16
Btbd16tm2b(EUCOMM)Hmgu
Body Composition (DEXA lean/fat) Fat/Body weight homozygote Male decreased total body fat amount 9.860700811259449E-5
Btbd16
Btbd16tm2b(EUCOMM)Hmgu
Body Composition (DEXA lean/fat) Fat/Body weight heterozygote Male decreased total body fat amount 9.860700811259449E-5
Btbd16
Btbd16tm2b(EUCOMM)Hmgu
Combined SHIRPA and Dysmorphology Skin color - tail homozygote Male abnormal skin coloration 9.980449976865202E-5
Btbd16
Btbd16tm2b(EUCOMM)Hmgu
Combined SHIRPA and Dysmorphology Skin color - tail heterozygote Male abnormal skin coloration 9.980449976865202E-5